Related Experiment Video
Updated: Jan 7, 2026

A Reporter Assay to Analyze Intronic microRNA Maturation in Mammalian Cells
Published on: June 16, 2022
Human Pumilio proteins use fuzzy multivalent hydrophobic interactions to recruit the CCR4-NOT deadenylase complex to
Elise B Dunshee1, Brenna A Saladin1, David J Turner2
1Department of Biochemistry, Molecular Biology, and Biophysics, University of Minnesota, Minneapolis, MN 55455, USA.
Abstract:
Pumilio (PUM) proteins are conserved RNA-binding proteins that control mRNAs involved in development, proliferation, and stem cell differentiation. Human PUM1 and PUM2 repress targets by recruiting the CCR4-NOT deadenylase complex through a metazoan-specific N-terminal repression domain (RD3), which is predicted to be intrinsically disordered. Here we dissect RD3 using cell-based reporter assays, protein interaction assays with recombinant proteins, and crosslinking mass spectrometry. We identify multiple short RD3 peptides that are sufficient for repression and bind directly to the C-terminal NOT module of CCR4-NOT, comprising CNOT1, CNOT2, and CNOT3 subunits. Crosslinking reveals numerous mutually exclusive contacts between RD3 and the NOT module, consistent with a multivalent "fuzzy" binding mode in which interactions are not defined by a single sequence or structure. Sequence scrambling shows that the linear amino acid order of RD3 is dispensable, whereas its physicochemical composition, in particular distributed aliphatic and aromatic residues, is essential for repression and CCR4-NOT binding. These findings support a model in which low-affinity, multivalent interactions between intrinsically disordered regions (IDRs) and effector complexes, governed by amino acid composition rather than precise sequence, underlie robust PUM-mediated repression, and exemplify general principles by which IDRs recruit the CCR4-NOT complex to regulate gene expression.
Insights
Pumilio (PUM) proteins use intrinsically disordered regions (IDRs) to bind the CCR4-NOT complex. This binding, driven by amino acid composition not sequence, enables robust gene repression.
Area of Science:
- Molecular Biology
- Gene Regulation
- Protein-RNA Interactions
Background:
- Pumilio (PUM) proteins are crucial RNA-binding proteins regulating gene expression during development and differentiation.
- Human PUM1 and PUM2 utilize an intrinsically disordered N-terminal repression domain (RD3) to recruit the CCR4-NOT deadenylase complex for mRNA repression.
Purpose of the Study:
- To dissect the mechanism by which the PUM protein repression domain (RD3) interacts with the CCR4-NOT complex.
- To elucidate the structural and compositional requirements for RD3-mediated gene repression.
Main Methods:
- Cell-based reporter assays to assess repression activity.
- Protein interaction assays using recombinant proteins.
- Crosslinking mass spectrometry to map protein-protein contacts.
Main Results:
- Short peptides within RD3 are sufficient for repression and directly bind the CNOT1, CNOT2, and CNOT3 subunits of the CCR4-NOT complex.
- Crosslinking data indicates multivalent, mutually exclusive interactions between RD3 and the NOT module, characteristic of a "fuzzy" binding mode.
- The physicochemical composition, specifically the distribution of aliphatic and aromatic residues, is critical for RD3 function, while linear amino acid sequence is dispensable.
Conclusions:
- Intrinsically disordered regions (IDRs) like RD3 employ low-affinity, multivalent interactions governed by amino acid composition to bind effector complexes.
- This mechanism provides robust PUM-mediated gene repression and exemplifies how IDRs recruit the CCR4-NOT complex for gene expression regulation.
Related Concept Videos
piRNA - Piwi-interacting RNAs
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
MicroRNAs
MicroRNAs
Experimental RNAi
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...

